Common Contracts
22 similar Employment Agreement contracts by Disc Medicine, Inc., PepGen Inc., Aerovate Therapeutics, Inc., SEMrush Holdings, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • November 7th, 2024 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Paul D. Streck, MD, MBA (the “Employee”) and is effective as of August 19, 2024 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2024 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Mary Beth DeLena and is effective as January 15th, 2024 (the “Effective Date”).
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 7th, 2024 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc., (the “Company”), and Jean Franchi (the “You”) and is effective as of the date this Agreement is fully executed by both parties (the “Effective Date”).
ACTIVE/123273267.1 2 (b) Incentive Compensation. You shall be eligible to receive cash incentive compensation as determined by the Board or the Compensation Committee from time to time. Your initial target annual incentive compensation shall be 100...Employment Agreement • November 1st, 2023 • SEMrush Holdings, Inc. • Services-prepackaged software • Massachusetts
ACTIVE/123273267.1 2 (b) Incentive Compensation. You shall be eligible to receive cash incentive compensation as determined by the Board or the Compensation Committee from time to time. Your initial target annual incentive compensation shall be 100...Employment Agreement • November 1st, 2023 • SEMrush Holdings, Inc. • Services-prepackaged software • Massachusetts
ACTIVE/123273267.1 2 “Target Bonus.” The actual amount of your annual incentive compensation, if any, shall be determined in the sole discretion of the Board or the Compensation Committee, subject to the terms of any applicable incentive compensation...Employment Agreement • September 14th, 2023 • SEMrush Holdings, Inc. • Services-prepackaged software • Massachusetts
ACTIVE/123273267.1 2 provided that any incentive compensation for calendar year 2023 will be prorated based on your hire date. The target annual incentive compensation in effect at any given time is referred to herein as “Target Bonus.” The actual...Employment Agreement • September 14th, 2023 • SEMrush Holdings, Inc. • Services-prepackaged software • Massachusetts
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2023 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc. (formerly Gemini Therapeutics, Inc.), (the “Company”), and William Savage, MD, Ph.D. (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company, regarding the subject matter herein, including without limitation the offer letter between you and Disc Medicine, Inc. dated June 28, 2020, as amended on July 1, 2021 (the “Prior Agreement”).
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2023 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc. (formerly Gemini Therapeutics, Inc.), (the “Company”), and Joanne Bryce, CPA (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company, regarding the subject matter herein, including without limitation the offer letter between you and Disc Medicine, Inc. dated September 14, 2021 (the “Prior Agreement”).
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2023 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc. (formerly Gemini Therapeutics, Inc.), (the “Company”), and Jonathan Yu (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company, regarding the subject matter herein, including without limitation the offer letter between you and Disc Medicine, Inc. dated May 4, 2020 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Niels Svenstrup(the “Executive”) and is effective as of March 21, 2023 (the “Effective Date”). Except with respect to the Continuing Obligations and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any prior offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and James McArthur (the “Executive”) and is effective as of March 21, 2023 (the “Effective Date”). Except with respect to the Continuing Obligations and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any prior offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Noel Donnelly(the “Executive”) and is effective as of March 21, 2023 (the “Effective Date”). Except with respect to the Continuing Obligations and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any prior offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Michelle Mellion(the “Executive”) and is effective as of March 21, 2023 (the “Effective Date”). Except with respect to the Continuing Obligations and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any prior offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • PepGen Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between PepGen Inc. (the “Company”), and Jaya Goyal (the “Executive”) and is effective as of March 21, 2023 (the “Effective Date”). Except with respect to the Continuing Obligations and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any prior offer letter, employment agreement or severance agreement.
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2022 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc. (formerly Gemini Therapeutics, Inc.), (the “Company”), and William Savage, MD, Ph.D. (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company, regarding the subject matter herein, including without limitation the offer letter between you and Disc Medicine, Inc. dated June 28, 2020, as amended on July 1, 2021 (the “Prior Agreement”).
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2022 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc., (the “Company”), and John D. Quisel, J.D., Ph.D. (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreements and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company regarding the subject matter herein, including without limitation the Employment Agreement between you and the Disc Medicine, Inc. dated October 30, 2019 (the “Prior Agreement”).
DISC MEDICINE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2022 • Disc Medicine, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Disc Medicine, Inc. (formerly Gemini Therapeutics, Inc.), (the “Company”), and Joanne Bryce, CPA (the “You”) and is effective as of the closing of the proposed business combination among the Company, Disc Medicine Opco, Inc. (formerly Disc Medicine, Inc.) and Gemstone Merger Sub, Inc. pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between you and Disc Medicine, Inc., predecessor in interest to the Company, regarding the subject matter herein, including without limitation the offer letter between you and Disc Medicine, Inc. dated September 14, 2021 (the “Prior Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 25th, 2021 • Aerovate Therapeutics, Inc. • Pharmaceutical preparations • California
This Employment Agreement (“Agreement”) is made between Aerovate Therapeutics Inc., a Delaware corporation (the “Company”), and Hunter Gillies, M.B.Ch.B. (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Equity Documents (as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation (i) the letter agreement between you and the Company dated April 27, 2020 (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • June 25th, 2021 • Aerovate Therapeutics, Inc. • Pharmaceutical preparations • California
This Employment Agreement (“Agreement”) is made between Aerovate Therapeutics Inc., a Delaware corporation (the “Company”), and Ralph Niven, Ph.D. (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Equity Documents (as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation (i) the letter agreement between you and the Company dated April 26, 2020 (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • June 25th, 2021 • Aerovate Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Aerovate Therapeutics Inc., a Delaware corporation (the “Company”), and Benjamin T. Dake, Ph.D. (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Equity Documents (as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation (i) the letter agreement between you and the Company dated November 4, 2019 (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • June 17th, 2021 • Aerovate Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Aerovate Therapeutics Inc., a Delaware corporation (the “Company”), and _____________________ (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Equity Documents (as defined below), this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation (i) the letter agreement between you and the Company dated ______ (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.
